Diabetic patients are at higher risk for certain diseases than non-diabetics; Among all types all diseases cancer has always been the most important [1]. In a number of studies, there is a possible link between diabetes and an increased risk of certain cancers, but the results are very scattered But the biological connection of these two diseases is very complicated and still not well understood. According to studies, there is a relationship between type 2 diabetes and some types of cancer such as breast cancer, uterine wall cancer, liver, bladder, colorectal and pancreas. However, there was no increase in the risk of developing other types of cancer in many people with diabetes. Findings show that some aspects of diabetes are a risk factor for cancer. Currently, a factor that is more important than other aspects of this relationship is the lifestyle factor that affects diabetes-obesity, physical inactivity, sedentary lifestyles, and bad nutritional behaviors. These factors make changes that affect the risk of cancer. The most important thing is that these factors increase the amount of insulin in the blood, Insulin, in addition to its effect on sugar metabolism, is known as a growth factor and can stimulate the growth of pre-cancerous and cancerous cells. By assessing available articles and studies, there was no clear evidence of the impact of diabetes drugs on the increased risk of cancer. Only some studies on metformin and a possible reduction in the risk of cancer and even the improvement of the prognosis of certain cancers, especially breast cancer, have been mentioned. Drugs can be used to treat cancer using nanoparticles [2][3].Nanoparticles have many uses, such as medicine and industry [4][5]. Different nanoparticles are used in drug delivery, for instances, liposomal nanoparticles Niosomal nanoparticles and Nano-Poly Butyl Cyanoacrylate [6][7][8][9][10][11]. As mentioned Diabetic patients also face thyroid dysfunction more than other individuals of the society. Both diabetes and thyroid dysfunction (TD) consider as main metabolic and endocrine disorders. On the other hand, the patients suffering from an autoimmune disease might be exposed to other autoimmunity diseases. Type 1 Diabetes mellitus (T1DM) is also an autoimmune disease. Thyroid disorder is more common in women than men. Women which affected by T1DM are more susceptible to TD compared to non-diabetic individuals [12][13]. The association of diabetes mellitus (DM) and TD was first examined in previous decades [14][15]. Autoimmune thyroid dysfunction (ATD) is associated with T1DM. The symptoms of hyperthyroidism within T1DM individuals might cause symptoms like weight loss in spite of increase of appetite, fatigue and so on [12][13][16][17][18]. The incidence of TD among patients with DM had varied ranges in different countries .some studies reported that the considerable percent of women are afflicted with TD. Thyroid disorder is dependent on sex, age and ethnicity of patients. The extent of inflammation in Thyroid glands in women afflicted with T1DM had various degrees [17][19][20][21][22][23][24][25][26][27][28][29].The relationship between thyroid dysfunction and T1DM is seems so complex and these associations affected by biochemical interactions. Indeed, clinical disorders in T1MD patients might be present without clinical symptoms. Based on author knowledge, it is necessary to define prevalence of clinical and sub-clinical thyroid dysfunction among T1DM patients especially women in our country. The aim of present study is defining TD prevalence in T1DM patients focusing on Iranian elderly women.

This case-control study conducted among TIDM patients who were referred to clinic diabetes of Tohid hospital in Sanandaj (west of Iran) during 2011-2012. The average age of diabetic patients were 52.2 ± 2.9 years that already diagnosed as TIDM for more than one year. The control group included mature and healthy women without T1DM with average age of 49/4 ± 3/2 years. The socio-demographic characteristics showed no significant difference between two groups. 12-hour overnight fasting was necessary for getting blood sample for measuring Fasting blood sugar (FBS). Blood sample were collected and serum were isolated(The serum samples from 68 patients of T1DM and 122 healthy individuals). Diagnosis parameters in patient group were done based on clinical symptoms like weight loss, Polyuria and polydipsia, overeating, and Insulin injection for more than one year.

Samples were analyzed for measuring FBS, Serum TSH, Anti-TPO and Free T4 by ELISA kit (Accu-Bind, USA). Amounts higher than 40 u/mL were regarded as positive for Anti-TPO. For measurement of TSH, CLIA microwells kit (Monobind, USA)were used which its normal amount was around 0.4-5.45 micu/mL.

The following biochemical characteristic of thyroid disorder observe in clinical and subclinical hypothyroidism: amount of TSH is >4.20 mIU/mL in both clinical and subclinical hypothyroidism. Amount of FT4 is <0.93 ng/dl and 0.93-1.7 ng/dl in clinical and subclinical hypothyroidism respectively.

subclinical hyperthyroidism is so that TSH level was less than 0.27 mIU/mL and FT4 levels more than 1.7ng/dl for FreeT4 level.

Autoimmunity with anti-TPO was diagnosed to be more than 34 IU/mL (22,29). Statistical analysis were done by SPSS (version 21). The results were reported in mean± SD format and comparison of two groups done through Chi-Square and T-test. Significance level were considered as P<0.05.

The average age for T1DM individuals were 52±2.4 years and 49.4± 3.2 years for case and control groups respectively. biochemical and demographic feature of studied population were shown in Table 1.

Among different types of human disorders, such as cancers, and metabolic diseases [30][31][32][33][34][35][36][37], diabetes could be considered as one of the furthermost significant illness [31].The aim of present study was to examine the existence of TD in elderly women with T1DM in comparison with control group( wholly constituted of female subjects). Almost one third of patients with T1DM had Thyrioid dysfunction or suffered from thyroid disorders. This issue can be justified in such a way that T1DM was an autoimmune disease and those with such a autoimmune disease are susceptible to other diseases of the same kind [24][26]. Thyroid diseases and TD are more common among women and also T1DM females may be more susceptible to TD compared to healthy female subjects [13][14][29]. The extent of inflammation in diabetic females especially those with TIDM seems to be more than healthy non-diabetic females. This will confirm this hypothesis that in type-one diabetic individuals the frequency of thyroid disorders is more [14][23].

TD might be without symptoms and these stigma may be sometimes misdiagnosed [27][28]. Our study confirms this fact that in the studied samples, the major percent of T1DM patients had subclinical TD. Sub-clinical hypothyroidism was a dysfunctional disorder observed in a significant percentage of studied patients which constituted 13.2 percent of T1DM individuals alike to the information of other studies [15][24]. Prevalence of anti-TPO in T1DM patients was considered as positive results which shown in noticeable percent of T1DM patients.

In present study, the average age of patients with positive Serum anti-TPO were more than patients with negative Anti-TPO. This issue is significant because these patients with clinical hyperthyroidism had a higher average age than other patients and this issue was confirmed in our study. In fact, sub-clinical thyroid disorders were made due to biochemical changes without any clinical symptoms.

In conclusion,Results show this fact that functional TD might be present with T1DM. In fact, altered levels of TSH and existence of anti-TPO might be mentioned as a problem for diabetic patients. Our study showed the association between autoimmune hypothyroidism and T1DM especially in those with positive serum regarding anti-TPO, so it is better to check these patients annually for diagnosis of TD. The screening programs for T1DM female patients would be decreases progression of subclinical TD and thyroid. High prevalence of both diseases and existence of TD among T1DM might necessitate this investigation.

We are thankful to Tohid hospital diabetes clinic laboratory workers and Mr.seifi from tohid hospital. we also appreciate from support of Mr. Semko Rashidi.

1 01 18 2017 10.22034/APJCP.2017.18.1.65 ebrahimifar meysam Hasanzadegan roudsari Majid Kazemi S Maryam Ebrahimi Shahmabadi Hasan Kanaani Leila Alavi S.A. Izadi Vasfi Mehdi Asian Pacific Journal of Cancer Prevention Enhancing Effects of Curcumin on Cytotoxicity of Paclitaxel, Methotrexate and Vincristine in Gastric Cancer Cells 56 4 65.10p 38 Oct/Nov2016 Azizi H et al Medical Journal of Tabriz University of Medical Sciences & Health Services The risk of colorectal cancer in type 2 diabetic patients 2011 Fatahi S Afsari A Fakhri M Bijan S International Congress on Breast Cancer The association between type 2 diabetes and the incidence of breast cancer 1 1 5 3 2013 Mohammadi H Abedi A et al International Nano Letters Evaluation of synthesized platinum nanoparticles on the MCF-7 and HepG-2 cancer cell lines 107 112 7 2016 Izadi M Ebrahimi Far M Kanaani L et al Advanced Biomedical Research Remove Nickel (II) From Drinking Water Using Thiol-Functionalized Chitosan 2502 2277 2009 Khalili M Akbarzadeh A et al Research Journal of Recent Sciences The effect of nanoliposomal and PE gylated nanoliposomal forms of 6-gingerol on breast cancer cells 1195 8 1198 13 2014 Esfahani MKM et al Tropical Journal of Pharmaceutical Research Pegylation of nanoliposomal paclitaxel enhances its efficacy in breast cancer 47 19 52 5 2015 Ahmadi L Chiani M et al New Cellular and Molecular Biotechnology Journal To evaluate the effect of formulation of Nanoarchaeosomal 6-gingerol on the growth of breast cancer MCF-7 cell line 335 342 2 2013 Zarei M Norouzian D Chiani M Ebrahimi H Mohammad M Akbarzadeh A Int J Life Sci Bt & Pharm Res Advantages of paclitaxel-loaded nano niosomes to nanoliposomal formulation: an in vitro study 2 02 18 2017 10.22034/APJCP.2017.18.2.365 Kanaani Leila javadi Iraj Ebrahimi-Far Meysam Ebrahimi shahmabadi Hasan Akbarzadeh Khiyavi Azim Mehrdiba Torkan Asian Pacific Journal of Cancer Prevention Effects of Cisplatin-Loaded Niosomal Nanoparticleson BT-20 Human Breast Carcinoma Cells 99 103 4 2014 Dadgar N Alavi E Moftakhari Esfahani M et al New Cellular and Molecular Biotechnology Journal Evaluation the cytotoxicity of nanoliposomal artemisinin on breast cancer cell line 1-7 2011 2011 10.4061/2011/439463 Hage Mirella Zantout Mira S. Azar Sami T. Journal of Thyroid Research Thyroid Disorders and Diabetes Mellitus 2 04 86-90 56 2001 10.1179/acb.2001.015 Proces S. Delgrange E. Vander Borght T. Jamart J. Donckier J.E. Acta Clinica Belgica MINOR ALTERATIONS IN THYROID – FUNCTION TESTS ASSOCIATED WITH DIABETES MELLITUS AND OBESITY IN OUTPATIENTS WITHOUT KNOWN THYROID ILLNESS 7 07 622-627 12 1995 10.1111/j.1464-5491.1995.tb00553.x Perros P. McCrimmon R.J. Shaw G. Frier B.M. Diabetic Medicine Frequency of Thyroid Dysfunction in Diabetic Patients: Value of Annual Screening 2010 10.4021/jocmr2010.03.281w Papazafiropoulou Athanasia Journal of Clinical Medicine Research Prevalence of Thyroid Dysfunction Among Greek Type 2 Diabetic Patients Attending an Outpatient Clinic 3 09 657-672 36 2007 10.1016/j.ecl.2007.04.007 Adler Suzanne Myers Wartofsky Leonard Endocrinology and Metabolism Clinics of North America The Nonthyroidal Illness Syndrome 01 4 04 1181-1185 26 2003 10.2337/diacare.26.4.1181 Umpierrez G. E. Latif K. A. Murphy M. B. Lambeth H. C. Stentz F. Bush A. Kitabchi A. E. Diabetes Care Thyroid Dysfunction in Patients With Type 1 Diabetes: A longitudinal study 41 48 54 2005 Prazny M Skrha J Limonova Z et al Physiological Re- search Sceen- ing for associated autoimmunity in type 1 diabetes mellitus with respect to diabetes control 6 01 20 2007 10.1515/jpem.2007.20.6.669 Mantovani R.M. Mantovani L.M. Dias V.M.A. Journal of Pediatric Endocrinology and Metabolism Thyroid Autoimmunity in Children and Adolescents with Type 1 Diabetes Mellitus: Prevalence and Risk Factors 01 4 04 1235-1240 26 2003 10.2337/diacare.26.4.1235 Hanukoglu A. Mizrachi A. Dalal I. Admoni O. Rakover Y. Bistritzer Z. Levine A. Somekh E. Lehmann D. Tuval M. Boaz M. Golander A. Diabetes Care Extrapancreatic Autoimmune Manifestations in Type 1 Diabetes Patients and Their First-Degree Relatives: A multicenter study 09 1 10 5 2013 10.1186/1758-5996-5-58 Palma Cátia Cristina Silva Sousa Vergara Pavesi Marco Nogueira Verônica Guedes Clemente Eliete Leão Silva Vasconcellos Maria de Fátima Bevilacqua Motta Pe Pereira Luiz Carlos Pacheco Fernanda Faissol Braga Tássia Gomide Bello Ludmila de Faria Soares Juliana Oliveira dos Santos Stefanie Cathren Fenizola Campos Vinícius Paes Leme Cavalcante Gomes Marília Brito Diabetology & Metabolic Syndrome Prevalence of thyroid dysfunction in patients with diabetes mellitus 6 12 481-493 7 1977 10.1111/j.1365-2265.1977.tb01340.x TUNBRIDGE W. M. G. EVERED D. C. HALL R. APPLETON D. BREWIS M. CLARK F. EVANS J. GRIMLEY YOUNG E. BIRD T. SMITH P. A. Clinical Endocrinology THE SPECTRUM OF THYROID DISEASE IN A COMMUNITY: THE WHICKHAM SURVEY 622 7 627 12 1995 Perros P McCrimmon RJ Shaw G Frier BM Diabetes Med Frequency of thyroid dysfunction in diabetic patients: value of annual screening 2 02 489-499 87 2002 10.1210/jcem.87.2.8182 Hollowell Joseph G. Staehling Norman W. Flanders W. Dana Hannon W. Harry Gunter Elaine W. Spencer Carole A. Braverman Lewis E. The Journal of Clinical Endocrinology & Metabolism Serum TSH, T4, and Thyroid Antibodies in the United States Population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III) 28 4 02 526 160 2000 10.1001/archinte.160.4.526 Canaris Gay J. Manowitz Neil R. Mayor Gilbert Ridgway E. Chester Archives of Internal Medicine The Colorado Thyroid Disease Prevalence Study 512 518 140 1999 Hansen D Bennedbaek FN Hansen LK Hoier-Madsen M Jacobsen BB Hegedüs L Eur J Endocrinol Thyroid function, morphology and autoimmunity in young Patients with insulin-dependent diabetes mellitus 01 1 01 27-32 24 2001 10.2337/diacare.24.1.27 Jaeger C. Hatziagelaki E. Petzoldt R. Bretzel R. G. Diabetes Care Comparative Analysis of Organ-Specific Autoantibodies and Celiac Disease--Associated Antibodies in Type 1 Diabetic Patients, Their First-Degree Relatives, and Healthy Control Subjects 509 513 59 2002 Kalicka-Kasperczyk A Dziatkowiak H Bratnik-Mi- kuta A et al Przegląd Lekarski Thyroid peroxidase antibodies and thyroid disease in children and adolescents with newly diagnosed type 1 diabetes 89 90 3 2014 Goodarzi MT Mohammadian M Borzouei Sh et al Int Res J Biological Sci Association between Plasma Cholesteryl Ester Transfer Protein activity and Lipid profiles in Metabolic Syndrome in an Iranian Population 28 9 09 3 2015 10.17265/2328-2150/2015.09.002 Mahshid Mohammadian Attabak Toofani Milani Mohammad Reza Hassas Siamak Rashidi Elmira Roshani Asl Sadegh Rostaminasab Mohadeseh Nemati Farid Javandust Narmin Mokarizadeh Farhad fathi younesi Journal of Pharmacy and Pharmacology Evaluation of Serum Iron, Zinc and Their Relationships with Glycemic Control Status in Iranian Elderly Women with Type 1 Diabetes Mellitus 02 30-38 684 2019 10.1016/j.gene.2018.10.016 Zeynali-Moghaddam Shima Mohammadian Mahshid Kheradmand Fatemeh Fathi-Azarbayjani Anahita Rasmi Yousef Esna-Ashari Omid Malekinejad Hassan Gene A molecular basis for the synergy between 17‑allylamino‑17‑demethoxy geldanamycin with Capecitabine and Irinotecan in human colorectal cancer cells through VEFG and MMP-9 gene expression 6 517 12 2017 10.4103/1735-5362.217432 Kheradmand Fatemeh Mohammadian Mahshid Zeynali Shima Azarbaijani AnahitaFathi Khadem Ansari MohammadHassan Research in Pharmaceutical Sciences Cytotoxic effects of the newly-developed chemotherapeutic agents 17-AAG in combination with oxaliplatin and capecitabine in colorectal cancer cell lines 133 5 140 6 2015 Rostaminasab S Noori S Yaghmaei B Rostaminasab Dolatabad M Toofani Milani A Mohammadian M Adv Biores Antitumor Immunostimulatory Effect of Sitosterol from Salvia atropatana on Tumor bearingmice 3 03 18 2017 10.22034/APJCP.2017.18.3.629 Mohamadi Nejad Kazemi S Maryam Mohammadian Mahshid Toofani Milani Attabak Moradi Younes Yasemi Maryam Ebrahimi Far Meysam Mazloumi Tabrizi Maral Ebrahimi Shahmabadi Hasan Akbarzadeh Khiyavi Azim Asian Pacific Journal of Cancer Prevention Toxicity of Cisplatin-Loaded Poly Butyl Cyanoacrylate Nanoparticles in a Brain Cancer Cell Line: Anionic Polymerization Results 70 16 75 8 2016 Sajjadiyan S Z Ghadernejad H Toofani Milani A Mohammadian M Abdolahpour S Taslimi S Moradi- Sardareh H Afrisham R Kooti W Der Pharmacia Lettre Preparation of silibinin loaded pegylatedniosomal nanoparticles and investigation of its effect on MCF-10A human breastcancer cell line 9 09 19 2018 10.22034/APJCP.2018.19.9.2391 Arshad Zhila Rezapour-Firouzi Soheila Mohammadian Mahshid Ebrahimifar Meysam Asian Pacific Journal of Cancer Prevention The Sources of Essential Fatty Acids for Allergic and Cancer Patients; a Connection with Insight into Mammalian Target of Rapamycin: A Narrative Review 19 6 03 1611-1612 30 2007 10.2337/dc06-2595 Gonzalez G. C. Capel I. Rodriguez-Espinosa J. Mauricio D. de Leiva A. Perez A. Diabetes Care Thyroid Autoimmunity at Onset of Type 1 Diabetes as a Predictor of Thyroid Dysfunction